Chip Scale Laser Fuels Portable Quantum, Vutrisiran Promises in ATTR CM, New ReNU2 Syndrome Reveals Severity, Fluvoxamine Reduces Long COVID Fatigue, and more...

(0:10): Breakthrough in Compact Quantum Computing: Chip-Scale Laser Drives Portable Quantum Devices(2:20): Alnylam's Vutrisiran Shows Promising Results in ATTR-CM; Robust Real-World Adherence Reported(4:44): Newly Identified ReNU2 Syndrome Sheds Light on Severe Childhood Epilepsy and Neurodevelopmental Disorders(7:16): Fluvoxamine Shows Promise in Reducing Long COVID Fatigue, Study Reveals(9:20): Study Warns Vaping May Trigger DNA Changes, Cancer Risks; Calls for Stricter RegulationsTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Stock Titan